Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02689531 · ClinicalTrials.gov registry record
CTTI Risk Factors for HABP/VABP Study
A clinical trial of Pneumonia, Bacterial and Pneumonia, Ventilator-Associated, sponsored by Duke University.
- Completed
- Registry status
- 7,530
- Enrollment target
- 15
- Study locations
NCT02689531 is a study of Pneumonia, Bacterial and Pneumonia, Ventilator-Associated that has completed, run by Duke University. The registered enrollment target is 7,530 participants, above the 273-participant average among 7 other Pneumonia, Bacterial trials with a reported enrollment target (2658% higher). The trial reports 15 study locations across 13 states.
The verdict
NCT02689531, a study of Pneumonia, Bacterial and Pneumonia, Ventilator-Associated, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 7,530 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to better define the intensive care unit population at highest risk for developing Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP).
Conditions Studied
Study Locations (15)
Michigan
- - Detroit
- - Royal Oak
Pennsylvania
- - Philadelphia
- - Pittsburgh
Alabama
- - Birmingham
California
- - Los Angeles
Illinois
- - Chicago
Kentucky
- - Louisville
Louisiana
- - New Orleans
Missouri
- - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,530 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02689531
The ClinicalTrials.gov registry entry for NCT02689531 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,530 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 273-participant average among 7 other Pneumonia, Bacterial trials with a reported enrollment target (2658% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pneumonia, Bacterial appearing as the primary indexed condition, and to 0 interventions.
NCT02689531 reports 15 study locations spanning 13 distinct geographic areas - top geographies include Michigan, Pennsylvania, Alabama.
Frequently Asked Questions
What is clinical trial NCT02689531 about?
NCT02689531 is a clinical study titled "CTTI Risk Factors for HABP/VABP Study". The purpose of this study is to better define the intensive care unit population at highest risk for developing Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP).
What is the current status of trial NCT02689531?
This trial is currently completed. The enrollment target is 7,530 participants. The study started on 2016-02. Estimated completion is 2018-02.
What conditions does trial NCT02689531 study?
This clinical trial studies the following conditions: Pneumonia, Bacterial, Pneumonia, Ventilator-Associated, Pneumonia, Hospital-Acquired.
Who is sponsoring clinical trial NCT02689531?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02689531 being conducted?
This trial has 15 study locations across Alabama, California, Illinois, Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia, Bacterial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
ACTIVE NOT RECRUITING · Phase 2
-
Discharge Stewardship in Children's Hospitals
ACTIVE NOT RECRUITING · NA
-
Pneumonia Direct Pilot
COMPLETED
-
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
COMPLETED · Phase 2
-
Urease Breath Test for Rapid Characterization of Pneumonia
COMPLETED
-
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.